Thu, Apr 17, 2014, 6:49 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • soundsgood02 soundsgood02 Sep 24, 2006 6:19 AM Flag

    Jack is confident...

    only 3 month of "later this year".

    Jack Talley, President and CEO, stated, "We are confident that the long-term prospects for the Company are positive and we are focused on meeting the compliance standards of the Nasdaq Global Market. To that end, we are steadily progressing towards the key milestones we have established for our Company. In particular, we remain on schedule to file our Marketing Authorization Application for Ceplene for Acute Myeloid Leukemia in Europe later this year, we are in the final stages of preparing our IND filing for EPC2407, a novel apoptosis inducer for certain types of cancer, and we are continuing to scale up manufacturing for EpiCept NP-1 and LidoPAIN BP in anticipation of the initiation of pivotal trials."

 
IMNP
3.90+0.05(+1.30%)Apr 17 2:34 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.